Literature DB >> 28459196

Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer.

Hongyu Gao1, Xiuwen Lan1, Sen Li1, Yingwei Xue1.   

Abstract

The matrix metalloproteinase-9, E-cadherin, and vascular endothelial growth factor play an important role in behavior of tumor cell growth, invasion, and metastasis. In this study, we investigated the relationships of matrix metalloproteinase-9, E-cadherin, and vascular endothelial growth factor expression with clinicopathological features and results of chemosensitivity tested by collagen gel droplet-embedded culture-drug sensitivity test in gastric cancer. Fresh specimens were used for collagen gel droplet-embedded culture-drug sensitivity test and paired fixed specimens were used for immunohistochemistry. Positive expression of matrix metalloproteinase-9 was associated with poorly differentiated carcinoma (p = 0.032), lymph node metastasis (p = 0.022), and tumor stage (p = 0.023). Negative expression of E-cadherin was associated with poorly differentiated carcinoma (p = 0.007), lymph node metastasis (p = 0.012), and tumor stage (p = 0.007). Positive expression of vascular endothelial growth factor was associated with tumor size (p = 0.040) and stage (p = 0.007). Collagen gel droplet-embedded culture-drug sensitivity test was successfully evaluated in 56 patients. Among them, 29 (51.7%) patients were resistant to TS-1 and 31 (55.3%) patients were resistant to L-OHP. The L-OHP resistance rate in vascular endothelial growth factor positive patients was significantly higher than that in negative patients (p = 0.031). The L-OHP resistance rate in E-cadherin negative patients was significantly higher than that in positive patients (p = 0.014). In conclusion, matrix metalloproteinase-9, E-cadherin, and vascular endothelial growth factor were involved in tumor invasion and metastasis. Positive expression of matrix metalloproteinase-9 and vascular endothelial growth factor and negative expression of E-cadherin were malignant markers for gastric cancer. Positive expression of vascular endothelial growth factor and negative expression of E-cadherin were associated with L-OHP resistance.

Entities:  

Keywords:  E-cadherin; Gastric cancer; chemosensitivity; collagen gel droplet–embedded culture–drug sensitivity test; matrix metalloproteinase-9; vascular endothelial growth factor

Mesh:

Substances:

Year:  2017        PMID: 28459196     DOI: 10.1177/1010428317698368

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  16 in total

Review 1.  Extracellular vesicles regulate immune responses and cellular function in intestinal inflammation and repair.

Authors:  Triet M Bui; Lorraine A Mascarenhas; Ronen Sumagin
Journal:  Tissue Barriers       Date:  2018-02-09

Review 2.  Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors.

Authors:  Bernadette Xin Jie Tune; Maw Shin Sim; Chit Laa Poh; Rhanye Mac Guad; Choy Ker Woon; Iswar Hazarika; Anju Das; Subash C B Gopinath; Mariappan Rajan; Mahendran Sekar; Vetriselvan Subramaniyan; Neeraj Kumar Fuloria; Shivkanya Fuloria; Kalaivani Batumalaie; Yuan Seng Wu
Journal:  J Oncol       Date:  2022-05-09       Impact factor: 4.501

Review 3.  Molecular pathogenesis and emerging targets of gastric adenocarcinoma.

Authors:  Abby Ivey; Hillary Pratt; Brian A Boone
Journal:  J Surg Oncol       Date:  2022-06       Impact factor: 2.885

4.  E-Cadherin Protein as a Potential Marker for Gastric Cancer and Its Association with Helicobacter Pylori- Induced Gastritis and Gastric Ulcer.

Authors:  Mustafa Kahtan Al-Bayaty; Salma Abdul-Rudha Abass; Mohammed Faraj Al-Marjani
Journal:  Rep Biochem Mol Biol       Date:  2019-10

5.  mRNA Expression Analysis of E-Cadherin, VEGF, and MMPs in Gastric Cancer: a Pilot Study.

Authors:  Puneet Kumar; Arun Sebastian; Khushi Verma; Ruhi Dixit; Soni Kumari; Juhi Singh; Satyendra Kumar Tiwary; Gopeshwar Narayan
Journal:  Indian J Surg Oncol       Date:  2020-05-22

6.  MicroRNA-128 targeting RPN2 inhibits cell proliferation and migration through the Akt-p53-cyclin pathway in colorectal cancer cells.

Authors:  Taicheng Zhou; Lili Wu; Qirui Wang; Zhipeng Jiang; Yingru Li; Ning Ma; Wenhao Chen; Zehui Hou; Wenchang Gan; Shuang Chen
Journal:  Oncol Lett       Date:  2018-09-26       Impact factor: 2.967

7.  The Phenolic compound Kaempferol overcomes 5-fluorouracil resistance in human resistant LS174 colon cancer cells.

Authors:  Ichrak Riahi-Chebbi; Soumaya Souid; Houcemeddine Othman; Meriam Haoues; Habib Karoui; Alain Morel; Najet Srairi-Abid; Makram Essafi; Khadija Essafi-Benkhadir
Journal:  Sci Rep       Date:  2019-01-17       Impact factor: 4.379

8.  FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition.

Authors:  Yanwei Ye; Jie Li; Dongbao Jiang; Jingjing Li; Chuangfeng Xiao; Yingze Li; Chao Han; Chunlin Zhao
Journal:  Cancer Res Treat       Date:  2020-05-25       Impact factor: 4.679

9.  Predictive Significance of Serum MMP-9 in Papillary Thyroid Carcinoma.

Authors:  Dahai Xu; Chang Su; Liang Guo; He Yan; Shaokun Wang; Congwang Yuan; Guohui Chen; Li Pang; Nan Zhang
Journal:  Open Life Sci       Date:  2019-07-10       Impact factor: 0.938

10.  Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1).

Authors:  Manish A Shah; Gyorgy Bodoky; Alexander Starodub; David Cunningham; Desmond Yip; Zev A Wainberg; Johanna Bendell; Dung Thai; Joyce He; Pankaj Bhargava; Jaffer A Ajani
Journal:  J Clin Oncol       Date:  2021-02-12       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.